Who founded VeraMorph?

VeraMorph was founded by Paul D. Godfrin, Doug Godfrin in 2022.

Who are VeraMorph's investors?

VeraMorph's investors include The Innovation Space.

How much funding has VeraMorph raised?

VeraMorph has disclosed $262.3K raised across 2 rounds.

Where is VeraMorph headquartered?

VeraMorph is headquartered in Mansfield, US.

VeraMorph

Mansfield, US · Founded 2022 · Delaware corporation · 1 known investors

VeraMorph is a drug delivery company that has developed a proprietary oral drug delivery platform used to improve solubility and clinical translation of poorly soluble compounds. It works with pharmaceutical companies and is building a portfolio of clinically differentiated oral versions of approved drugs.

Biotech Medical Devices

Founders & leadership

VeraMorph was founded in 2022 by Paul D. Godfrin and Doug Godfrin.

Paul D. GodfrinCo-founder

Doug GodfrinFounder, CEO & President

Investors · 1

The Innovation SpaceWilmington · $200K

Reported raises · per SEC filings

Form D private placements

$262.3K disclosed across 2 rounds · 2022–2023

▶$40KraisedApr 2023 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Paul D. GodfrinExecutive Officer, Director

Offering amount: $500K
Amount sold: $40K
First sale: Mar 2023
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$222.3KraisedAug 2022 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Paul D. GodfrinExecutive Officer, Director

Offering amount: $1M
Amount sold: $222.3K
First sale: Aug 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

VeraMorph Awarded an SBIR Fast Track Grant by NCI Towards Commercialization of the First Effective Oral Fulvestrant Therapy for ER+ Metastatic Breast Cancerbusinesswire.com · Oct 2025

Frequently asked questions

What does VeraMorph do?: VeraMorph is a drug delivery company that has developed a proprietary oral drug delivery platform used to improve solubility and clinical translation of poorly soluble compounds. It works with pharmaceutical companies and is building a portfolio of clinically differentiated oral versions of approved drugs.
Who founded VeraMorph?: VeraMorph was founded by Paul D. Godfrin, Doug Godfrin in 2022.
Who are VeraMorph's investors?: VeraMorph's investors include The Innovation Space.
How much funding has VeraMorph raised?: VeraMorph has disclosed $262.3K raised across 2 rounds.
Where is VeraMorph headquartered?: VeraMorph is headquartered in Mansfield, US.